Francesco Zaja The exciting recent ASH conference reflected the vibrant mood of an America boldly tackling economic and political turmoil with post-presidential-election optimism. Peter Goodwin and Ge
Francesco Zaja
The exciting recent ASH conference reflected the vibrant mood of an America boldly tackling economic and political turmoil with post-presidential-election optimism. Peter Goodwin andGeorge Canellosreflect on some of the big stories and talk with key investigators in San Francisco.Francesco Zajarecounts how rituximab has proved effective for treating immune thrombocytopenic purpura (ITP);Hannes Wandtpresents compelling data suggesting that platelet transfusions can be withheld in many patients receiving stem cell transplants for their hematologic malignancies; and bothMichael HallekandTadeusz Robakannounce Phase III study findings of improved benefits for patients whose chronic lymphocytic leukemia has been treated by adding rituximab to standard chemotherapy. The ASH President,Kenneth Kaushansky, plusLinda BurnsandGeorge Canelloscontribute their comments to put the new findings into clinical perspective for the busy oncologist.
Kenneth Kaushansky
George Canellos
Hannes Wandt
Linda Burns
Related Episodes
Li Zhang MD; ESMO 2025: Patients with EGFR-mutated Lung Cancer Progressing After Tyrosine Kinase Therapy Live Longer with Sacituzumab Tirumotecan Therapy
Antibody Drug Conjugate Prolongs Life in NSCLC refractory to EGFR TKI Therapy
Rebecca Dent MD: ESMO Previous Highlights: Neo-Adjuvant Therapy for Triple Negative Breast Cancer, Checkpoint Inhibition, AI, Cancer Vaccines, and More ……
Rebecca Dent surveys the most recent ESMO Annual Meeting to prepare our thoughts for the ESMO 2025 meeting
